Amanote Research
Register
Sign In
Letter: Hepatocellular Carcinoma Risk After Hepatitis B Surface Antigen Seroclearance
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/apt.13983
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
April 3, 2017
Authors
J.-F. Jiang
J. Sun
J. Shi
X. Liu
Publisher
Wiley
Related search
Letter: Hepatocellular Carcinoma Risk After Hepatitis B Surface Antigen Seroclearance - Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Older Age and Male Gender Increase the Risk of Hepatocellular Carcinoma After Hepatitis B Surface Antigen (HBsAg) Seroclearance
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Systematic Review With Meta-Analysis: Development of Hepatocellular Carcinoma in Chronic Hepatitis B Patients With Hepatitis B Surface Antigen Seroclearance
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Hepatitis B Surface Antigen Seroclearance During Chronic HBV Infection
Antiviral Therapy
Infectious Diseases
Pharmacology
Additive Effect Modification of Hepatitis B Surface Antigen and E Antigen on the Development of Hepatocellular Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Hepatitis B Virus Infection and Hepatocellular Carcinoma: Correlation Between IgM Antibody to Hepatitis B Core Antigen, Hepatitis B E Antigen, and Hepatitis B DNA
American Journal of Tropical Medicine and Hygiene
Medicine
Virology
Parasitology
Infectious Diseases
Decrease Trend in Proportions of Hepatitis B Surface Antigen Carrier in Chronic Hepatitis, Cirrhosis and Cirrhosis With Hepatocellular Carcinoma.
Japanese Journal of Tropical Medicine and Hygiene
Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B E Antigen Seroconverters
Gastroenterology
Hepatology
Gastroenterology
Letter: Samples for Hepatitis B Antigen Testing.
BMJ
